Log in to search using one of your social media accounts:

 

High blood pressure - is THIS really the safest way of treating hypertension?

LOWERING blood pressure to a level less than what is considered to be a normal blood pressure could benefit patients. However, now experts have said this method could actually harm people rather than help them.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

CONCLUSION: Needs for hospitalization among PLWH remain important, with a wide variety in causes of admission, involving all hospital departments. It is essential to prevent comorbidities to reduce these hospitalizations, and to maintain a link between the management of PLWH, that becomes rightly, increasing ambulatory, and recourse to specialized inpatient services. PMID: 29233572 [PubMed - as supplied by publisher]
Source: Revue d Epidemiologie et de Sante Publique - Category: Epidemiology Tags: Rev Epidemiol Sante Publique Source Type: research
Authors: Elliott WJ Abstract Preview Hypertension is a common target of cost-containment measures because so many people receive so much medication for it. However, to paraphrase Oscar Wilde's sentiments on being talked about: There is only one thing worse than the cost of treating hypertension, and that may be the cost of not treating hypertension. Dr Elliott describes some reasonable methods of cutting down on drug costs that do not result in insufficient or more costly medical care in the long term. PMID: 29231117 [PubMed]
Source: Postgraduate Medicine - Category: Internal Medicine Tags: Postgrad Med Source Type: research
In conclusion, Lycosin-I has the potential to be an anti-hypertensive drug by endothelium-dependent vasodilatation, in which eNOS and NO-sensitive sGC are two main involved factors.
Source: Peptides - Category: Biochemistry Source Type: research
Conclusion: Eight metabolites are potential biomarkers for AD, 3 of which were differentially expressed and can be used for auxiliary diagnosis of AD and evaluation of treatment effectiveness.Cell Physiol Biochem 2017;44:2147 –2157
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
CONCLUSIONS: The triple combination therapy with AZL/AML/HCTZ was well tolerated and effective for 52 weeks in Japanese patients with essential hypertension. PMID: 29235365 [PubMed - as supplied by publisher]
Source: Blood Pressure - Category: Hematology Tags: Blood Press Source Type: research
By MARGALIT GUR-ARIE A few weeks ago one man, named @jack, decided that millions of people will be allowed to use up to 280 characters when expressing themselves on Jack’s public square platform. One man decides how many letters each and every one of us, including the “leader of the free world”, can use when we talk to each other. Just like that. Nobody seemed the least bit perturbed by this notion. Another dude, named Mark, decided to ask people for nude pictures of themselves, so he can better protect them from the bad guys. We shrugged that off too. Then, in a most embarrassing exercise in public humil...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Uncategorized Dopamine Labs Keytruda Mark Zuckerberg Sean Parker Techno-drugs Source Type: blogs
Conditions:   Blood Pressure;   Hypertension;   Kidney Transplant; Complications;   Dietary Modification Intervention:   Other: Dietary salt reduction Sponsor:   Epsom and St Helier University Hospitals NHS Trust Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Hypertension Arterial Interventions:   Other: Patient not SAHOS;   Other: Patient SAHOS sailed by the ventilation in PPC and not sailed Sponsor:   Centre Hospitalier Universitaire de Pointe-a-Pitre Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Stent Stenosis;   Intracranial Hypertension;   Headache;   Tinnitus;   Papilledema;   Visual Impairment Interventions:   Procedure: Venous stenting for internal jugular vein stenosis;   Procedure: One-month routine medical treatment followed by venous stenting for internal jugular vein stenosis Sponsor:   Capital Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Blood Pressure;   Hypertension;   Kidney Transplant; Complications;   Dietary Modification Intervention:   Other: Dietary salt reduction Sponsor:   Epsom and St Helier University Hospitals NHS Trust Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Health | Hypertension